Therefore, the purpose of this study was to evaluate the association of ABCB1 polymorphisms, adverse event, PFS and pharmacokinetic parameters in Chinese lung cancer patients treated with taxane‐based chemotherapy. This evidence concerns the gene ABCB1 and lung carcinoma.